Justin Renz
Director of Finance/CFO at ARDELYX, INC.
Net worth: 2 M $ as of 2024-03-30
Profile
Justin A.
Renz is currently the Chief Operations & Financial Officer at Ardelyx, Inc. He previously held positions as the Senior Director-Global Accounting & Finance at Coley Pharmaceutical Group, Inc., Director-Accounting & Financial Operations at EMD Serono, Inc., Principal at EMD Millipore Corp.
and ArQule, Inc., President & Chief Financial Officer at Correvio Pharma Corp., CFO, Treasurer & General Counsel & SVP at CombinatoRx, Inc., and Chief Financial Officer, Treasurer & Executive VP at Karyopharm Therapeutics, Inc. Mr. Renz received his undergraduate degree from the College of the Holy Cross (Massachusetts), an MBA from Suffolk University, and a graduate degree from Northeastern University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ARDELYX, INC.
0.13% | 2024-02-19 | 304,835 ( 0.13% ) | 2 M $ | 2024-03-30 |
Justin Renz active positions
| Companies | Position | Start |
|---|---|---|
| ARDELYX, INC. | Director of Finance/CFO | 2020-06-08 |
Former positions of Justin Renz
| Companies | Position | End |
|---|---|---|
| CORREVIO PHARMA CORP. | Director of Finance/CFO | 2020-05-26 |
| KARYOPHARM THERAPEUTICS INC. | Director of Finance/CFO | 2017-04-02 |
CombinatoRx, Inc.
 CombinatoRx, Inc. Pharmaceuticals: OtherHealth Technology CombinatoRx, Inc. develops new medicines built from synergistic combinations of approved drugs. The company develops biopharmaceutical products. It conducts clinical trials and research programs. The company was founded by Alexis Borisy, Brent R. Stockwell, Michael A. Foley, Curtis T. Keith and Jacob D. Goldfield in 2000 and is headquartered in Cambridge, MA | Director of Finance/CFO | 2013-12-31 |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Comptroller/Controller/Auditor | 2006-09-01 |
Coley Pharmaceutical Group, Inc.
 Coley Pharmaceutical Group, Inc. Pharmaceuticals: MajorHealth Technology Coley Pharmaceutical Group, Inc. manufactures drugs to treat chronic diseases. The company discovers and develops receptors therapeutic candidates for cancers, asthma, and allergic disorders. It was founded in 1997 and is headquartered in Wellesley, MA | Director of Finance/CFO | 2004-12-31 |
Training of Justin Renz
| College of the Holy Cross (Massachusetts) | Undergraduate Degree |
| Suffolk University | Masters Business Admin |
| Northeastern University | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| KARYOPHARM THERAPEUTICS INC. | Health Technology |
| ARDELYX, INC. | Health Technology |
| Private companies | 7 |
|---|---|
EMD Millipore Corp.
 EMD Millipore Corp. Miscellaneous Commercial ServicesCommercial Services EMD Millipore Corp. engages in the provision of laboratory materials, technologies, and services to the life science industry. The company was founded by Jack Bush in 1954 and is headquartered in Burlington, MA. | Commercial Services |
ArQule, Inc.
 ArQule, Inc. Pharmaceuticals: MajorHealth Technology ArQule, Inc. is a biopharmaceutical company, which engages in the research and development of therapeutics to treat cancers and rare diseases. The company was founded in 1993 and is headquartered in Burlington, MA. | Health Technology |
Coley Pharmaceutical Group, Inc.
Coley Pharmaceutical Group, Inc. Pharmaceuticals: MajorHealth Technology Coley Pharmaceutical Group, Inc. manufactures drugs to treat chronic diseases. The company discovers and develops receptors therapeutic candidates for cancers, asthma, and allergic disorders. It was founded in 1997 and is headquartered in Wellesley, MA | Health Technology |
Correvio Pharma Corp.
 Correvio Pharma Corp. Pharmaceuticals: MajorHealth Technology Correvio Pharma Corp. operates as a pharmaceutical company, which engages in the provision of development and commercialization of medical products. It operates through the Europe and Rest of the World geographical segments. The firm focuses on cardiovascular therapies that will improve the quality of life and health of patients suffering from heart disease. It offers the Brinavess and Aggrastat products to customers such as physicians, patients and healthcare systems. The company was founded in 1986 and is headquartered in Vancouver, Canada. | Health Technology |
CombinatoRx, Inc.
CombinatoRx, Inc. Pharmaceuticals: OtherHealth Technology CombinatoRx, Inc. develops new medicines built from synergistic combinations of approved drugs. The company develops biopharmaceutical products. It conducts clinical trials and research programs. The company was founded by Alexis Borisy, Brent R. Stockwell, Michael A. Foley, Curtis T. Keith and Jacob D. Goldfield in 2000 and is headquartered in Cambridge, MA | Health Technology |
Arthur Andersen LLP
 Arthur Andersen LLP Miscellaneous Commercial ServicesCommercial Services Arthur Andersen LLP used to provide accounting services. It was also into consulting services for clients that operate businesses throughout the United States and around the world. Arthur Andersen was founded in 1913 and was headquartered in Chicago, IL. | Commercial Services |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Health Technology |
- Stock Market
- Insiders
- Justin Renz
